Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile

Clinical Medicine Insights: Gastroenterology - New Zealand
doi 10.1177/1179552217728905
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Review Article: Potential Mechanisms of Action of Rifaximin in the Management of Irritable Bowel Syndrome With Diarrhoea

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2015English

Comparison of Various Treatment for Irritable Bowel Syndrome

BMJ
1980English

Clinical Potential of Eluxadoline in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

Therapeutics and Clinical Risk Management
2016English

Evaluation of Drug Treatment in Irritable Bowel Syndrome

British Journal of Clinical Pharmacology
Pharmacology
2003English

Irritable Bowel Syndrome

JAMA - Journal of the American Medical Association
Medicine
2015English

Virtual Reality as a Treatment for Irritable Bowel Syndrome

2011English

Irritable Bowel Syndrome

2013English

Irritable Bowel Syndrome

2012English

Irritable Bowel Syndrome

2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy